Telik Inc (OTCQB:TELK)

Data as of 12:42pm ET
 -0.0899 / -11.24%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA.

Contact Information

Telik, Inc.
2100 Geng Road
Palo Alto California 94303
P:(650) 845-7700
Investor Relations:
(650) 845-7712



Other institutional7.07%
Individual stakeholders15.99%
Mutual fund holders0.26%

Top Executives

John David HansenPresident, Chief Executive Officer & Director
Gregory P. HansonChief Financial Officer
Gail L. BrownChief Medical Officer & Senior Vice President
Philip O. LivingstonDirector & Chief Science Officer
Wolfgang W. ScholzVice President-Antibody Discovery

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.